Gadobutrol is a second-generation, non-ionic macrocyclic gadolinium-based contrast agent (GBCA) used in magnetic resonance imaging (MRI). It is formulated at a higher gadolinium concentration than other GBCAs, requiring a smaller injection volume, and the macrocyclic structure is associated with a lower risk of nephrogenic systemic fibrosis (NSF).
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 138071-82-6
Calcobutrol
chelating agent for diagnostic imaging
Gadobutrol
MRI contrast agent
2,2'-(4,10-bis(1,3,4-Trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid
chelating agent intermediate
2,2'-(4,10-Bis(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid tetrahydrochloride
Gadobutrol impurity reference standard
아고멜라틴
active pharmaceutical ingredient
Levofloxacin hydrate
active pharmaceutical ingredient
Tropifexor
active pharmaceutical ingredient
이르베사르탄
active pharmaceutical ingredient
2-[4,10-bis(carboxylatomethyl)-7-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
ZPDFIIGFYAHNSK-CTHHTMFSSA-K
C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])[C@H](CO)[C@@H](CO)O)CC(=O)[O-].[Gd+3]